Biotransformation of pantoprazole by the fungus Cunninghamella blakesleeana

Xenobiotica

Volumn 35, Issue 5, 2005, Pages 467-477

  Xie, Z Y ^a   Huang, H H ^a   Zhong, Dafang F ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cunninghamella blakesleeana; Glucosidation; Liquid chromatography mass spectrometry; Microbial transformation; Pantoprazole

Indexed keywords

4' O NORPANTOPRAZOLE THIOETHER; 6 HYDROXYPANTOPRAZOLE THIOETHER; DRUG METABOLITE; OMEPRAZOLE; PANTOPRAZOLE; PANTOPRAZOLE THIOETHER; PANTOPRAZOLE THIOETHER 1 N BETA GLUCOSIDE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CUNNINGHAMELLA; CUNNINGHAMELLA BLAKESLEEANA; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; FERMENTATION; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BIOTRANSFORMATION; CUNNINGHAMELLA; ENZYME INHIBITORS; H(+)-K(+)-EXCHANGING ATPASE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; OMEPRAZOLE; SULFOXIDES;

CUNNINGHAMELLA; CUNNINGHAMELLA BLAKESLEEANA; CUNNINGHAMELLA ECHINULATA; CUNNINGHAMELLA ELEGANS; FUNGI; MAMMALIA;

EID: 22944438036     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250500111414     Document Type: Article

References (17)

1. Abourashed EA, Clark AM, Hufford CD. 1999. Microbial models of mammalian metabolism of xenobiotics: An updated review. Current Medicinal Chemistry 6:359-364.
2. Cerniglia CE, Freeman JP, Mitchum RK. 1982. Glucuronide and sulfate conjugation in the fungal metabolism of aromatic hydrocarbons. Applied and Environmental Microbiology 43:1070-1075.
3. Chatterjee P, Pezzuto JM, Kouzi SA. 1999. Glucosidation of betulinic acid by Cunninghamella species. Journal of Natural Products 62:761-763.
4. Chen XY, Zhao LM, Zhong DF. 2003. An novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients. British Journal of Clinical Pharmacology 55:570-578.
5. Clark AM, Hufford CD. 1991. Use of microorganisms for the study of drug metabolism: an update. Medical Research and Review 11:473-501.
6. Davis PJ. 1988. Microbial models of mammalian drug metabolism. Developments in Industrial Microbiology 29:197-219.
7. Huber R, Hartmann M, Bliesath H, Luhmann R, Steinijans VW, Zech K. 1996. Pharmacokinetics of pantoprazole in man. International Journal of Clinical Pharmacology and Therapeutics 34(Supplement 1):S7-S16.
8. Jungnickel PW. 2000. Pantoprazole: a new proton pump inhibitor. Clinical Therapeutics 22, 1268-1293.
9. Masubuchi N, Yamazaki H, Tanaka M. 1998. Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats. Chirality 10:747-753.
10. 14C- labelled pantoprazole to young healthy male volunteers. Pharmacy World & Science 17(Supplement L):L7.
11. Rosazza JP. 1982. Microbial transformations of bioactive compounds. Boca Raton, FL: CRC Press, pp 1-11.
12. Simon WA. 1995. Pantoprazole-which cytochrome P450 isoenzymes are involved in its biotransformation. Gut 37(Supplement 2):A135.
13. Sun L, Liu L, Huang HH, Zhong DF. 2004. Transformation of verapamil by Cunninghamella blakesleeana. Applied and Environmental Microbiology 70:2722-2727.
14. Tanaka M, Ohkubo T, Otani K, Suzuki A, Kaneko S, Sugawara K, Ryokawa Y, Hakusui H, Yamamori S, Ishizaki T. 1997. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4′-hydroxylation phenotype and genotype. Clinical Pharmacology and Therapeutics 62:619-628.
15. Tucker GT. 1994. The interaction of proton pump inhibitors with cytochromes P450. Aliment Pharmacology Therapeutics, 8(Supplement 1):33-38.
16. Zhong DF, Sun L, Liu L, Huang HH. 2003. Microbial transformation of naproxen by Cunninghamella species. Acta Pharmacologica Sinica 24:442-447.
17. Zhong DF, Xie ZY, Chen XY. In press. Metabolism of pantoprazole involving conjugation with glutathione in rats. Journal of Pharmacy and Pharmacology 57:341-349.